Login / Signup

Synthesis, In Silico, and Biological Evaluation of a Borinic Tryptophan-Derivative That Induces Melatonin-like Amelioration of Cognitive Deficit in Male Rat.

Mónica Barrón-GonzálezMartha C Rosales-HernándezAntonio Abad-GarcíaAna L Ocampo-NéstorJosé Martín Santiago-QuintanaTeresa Pérez-CapistranJosé Guadalupe Trujillo FerraraItzia Irene Padilla-MartínezEunice D Farfán-GarcíaMarvin Antonio Soriano-Ursúa
Published in: International journal of molecular sciences (2022)
Preclinical and clinical evidence supports melatonin and its analogues as potential treatment for diseases involving cognitive deficit such as Alzheimer's disease. In this work, we evaluated by in silico studies a set of boron-containing melatonin analogues on MT1 and MT2 receptors. Then, we synthesized a compound (borolatonin) identified as potent agonist. After chemical characterization, its evaluation in a rat model with cognitive deficit showed that it induced ameliorative effects such as those induced by equimolar administration of melatonin in behavioral tests and in neuronal immunohistochemistry assays. Our results suggest the observed effects are by means of action on the melatonin system. Further studies are required to clarify the mechanism(s) of action, as the beneficial effects on disturbed memory by gonadectomy in male rats are attractive.
Keyphrases
  • molecular docking
  • risk assessment
  • case control
  • working memory
  • diabetic rats
  • molecular dynamics simulations
  • cell therapy
  • combination therapy